Company Filing History:
1 out of 3,100 
1 out of 41,498 
1 out of 1 Years Active: 2024-2025
Title: Shuang Wang: Innovator in Coagulation Factor Research
Introduction
Shuang Wang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapies related to coagulation factors. With a total of 3 patents, his work has the potential to impact the treatment of various medical conditions.
Latest Patents
One of Wang's latest patents is titled "FVIII fusion protein and use thereof." This patent discloses a coagulation factor VIII fusion protein that is conjugated with polyalkylene glycol, resulting in an extended cyclic half-life. The active moiety of the coagulation factor VIII is linked to a fusion partner, enhancing its efficacy. The half-life of this fusion protein is significantly increased compared to those modified without polyalkylene glycol.
Another notable patent is "Method of making exosomes from tumor cell/antigen presenting cell hybrid cells." This patent provides a method for creating exosomes secreted by hybrid cells formed when antigen-presenting cells phagocytose the cell nuclei of tumor cells. This innovative approach allows for endogenous expression of tumor antigens on macrophages, resulting in exosomes that effectively target lymph nodes and tumors.
Career Highlights
Shuang Wang has worked with esteemed organizations such as the Chinese Academy of Sciences and Qualcomm Incorporated. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Wang has collaborated with notable colleagues, including Guanghui Ma and Wei Wei, who is a woman. These collaborations have further enriched his research and innovation efforts.
Conclusion
Shuang Wang's contributions to the field of biomedical research, particularly in coagulation factors and exosome technology, highlight his role as an influential inventor. His innovative patents and collaborations with esteemed organizations and colleagues underscore his commitment to advancing medical science.